AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-248647897/us-fda-clears-use.html" title="Facts and information about US FDA clears use of Novartis' Menveo for over two-year-olds; Depomed leaps on approval of shingles drug Gralise.">US FDA clears use of Novartis' Menveo for over two-year-olds; Depomed leaps on approval of shingles drug Gralise.</a>
Close
Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
Frequently asked questions about RSS feeds
US FDA clears use of Novartis' Menveo for over two-year-olds; Depomed leaps on approval of shingles drug Gralise.
The US Food and Drug Administration (FDA) has approved Swiss drug major Novartis' Menveo [meningococcal (Groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine] for active immunisation to prevent invasive meningococcal disease caused by Neisseria meningitidis …
Related articles from newspapers, magazines, journals, and more
-
- FDA clears Vasogen to initiate pivotal Phase III clinical trial in chronic...
-
News wire article from: Asia Africa Intelligence Wire
November 19, 2002
700+ words
-
- FDA clears BristolMyers' YERVOY for treatment of metastatic melanoma.
-
News wire article from: Europe Intelligence Wire
March 28, 2011
700+ words
-
- FDA clears XARELTO for deep vein thrombosis prevention.
-
News wire article from: Europe Intelligence Wire
July 4, 2011
700+ words
-
- FDA clears Lundbeck's antiepileptic Onfi.
-
News wire article from: Europe Intelligence Wire
October 24, 2011
700+ words
